These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17671187)

  • 21. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
    Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
    Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction.
    Yakubov B; Chen L; Belkin AM; Zhang S; Chelladurai B; Zhang ZY; Matei D
    PLoS One; 2014; 9(2):e89285. PubMed ID: 24586660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
    Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML
    Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.
    Usui A; Ko SY; Barengo N; Naora H
    Mol Cancer Res; 2014 Apr; 12(4):504-13. PubMed ID: 24448686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma.
    Dong Y; Tan OL; Loessner D; Stephens C; Walpole C; Boyle GM; Parsons PG; Clements JA
    Cancer Res; 2010 Apr; 70(7):2624-33. PubMed ID: 20332224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer.
    Chu Y; Tang H; Guo Y; Guo J; Huang B; Fang F; Cai J; Wang Z
    Exp Cell Res; 2015 Sep; 337(1):16-27. PubMed ID: 26209607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
    Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
    Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of endostatin to human ovarian cancer cells inhibits cell attachment.
    Yokoyama Y; Ramakrishnan S
    Int J Cancer; 2007 Dec; 121(11):2402-9. PubMed ID: 17597104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of asparaginyl endopeptidase promotes growth potential in epithelial ovarian cancer.
    Zhu Q; Tang M; Wang X
    Cancer Biol Ther; 2017 Apr; 18(4):222-228. PubMed ID: 28278071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
    Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
    Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
    Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
    Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models.
    Kishikawa T; Sakamoto M; Ino Y; Kubushiro K; Nozawa S; Hirohashi S
    Invasion Metastasis; 1995; 15(1-2):11-21. PubMed ID: 7545653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
    Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of tissue transglutaminase expression in malignant melanoma.
    Fok JY; Ekmekcioglu S; Mehta K
    Mol Cancer Ther; 2006 Jun; 5(6):1493-503. PubMed ID: 16818508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.
    Hashimoto K; Morishige K; Sawada K; Tahara M; Kawagishi R; Ikebuchi Y; Sakata M; Tasaka K; Murata Y
    Cancer Res; 2005 Jan; 65(2):540-5. PubMed ID: 15695397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
    Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
    J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
    Sawada K; Mitra AK; Radjabi AR; Bhaskar V; Kistner EO; Tretiakova M; Jagadeeswaran S; Montag A; Becker A; Kenny HA; Peter ME; Ramakrishnan V; Yamada SD; Lengyel E
    Cancer Res; 2008 Apr; 68(7):2329-39. PubMed ID: 18381440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
    Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.
    Shibata K; Kikkawa F; Nawa A; Suganuma N; Hamaguchi M
    Cancer Res; 1997 Dec; 57(23):5416-20. PubMed ID: 9393769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.